Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A home-based, non-invasive sleep mask to treat diabetic retinopathy has been adopted by a hospital network within the UK’s National Health Service (NHS).
PolyPhotonix’s Noctura 400 sleep mask has reportedly been adopted by Ashford and St Peter’s NHS Foundation Trust, which is the largest provider of acute hospital services to residents in the county of Surrey in south east England.
According to reports, the Noctura 400 Sleep has been shown to improve patients’ visual acuity, and could potentially save the NHS millions of pounds a year.
Backed by the RENDER Study, the device has demonstrated improvement and stabilisation of diabetic eye disease in 96% of patients. It is an early-stage non-invasive alternative to current, later-stage invasive treatments such as eye injections for patients with the condition; which is a leading cause of blindness in Europe.
www.insightnews.com.au
Interesting 🙂
PolyPhotonix’s Noctura 400 sleep mask has reportedly been adopted by Ashford and St Peter’s NHS Foundation Trust, which is the largest provider of acute hospital services to residents in the county of Surrey in south east England.
According to reports, the Noctura 400 Sleep has been shown to improve patients’ visual acuity, and could potentially save the NHS millions of pounds a year.
Backed by the RENDER Study, the device has demonstrated improvement and stabilisation of diabetic eye disease in 96% of patients. It is an early-stage non-invasive alternative to current, later-stage invasive treatments such as eye injections for patients with the condition; which is a leading cause of blindness in Europe.
Sleep mask for diabetic retinopathy adopted by NHS hospital network
A sleep mask to treat diabetic retinopathy has been adopted by a hospital network within the UK’s National Health Service NHS.
www.insightnews.com.au
Interesting 🙂
